DSIP
Nonapeptide studied for sleep architecture, stress modulation, and pain. Limited modern human trial data.
At a glance
- Common vial size
- 5 mg
- Reference dose
- 200 mcg
- Frequency
- Pre-sleep
Reference titration protocol
25 nmol/kg IV/SC nightly (~1700 mcg @ 80 kg) × 5–10 consecutive evenings.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 1.7 mg | 4 weeks | 7× |
A 5 mg vial reconstituted with 2 mL of bacteriostatic water yields 2.5 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.
Open this configuration in the calculatorAvailable formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- Injectable503A
- Lyophilized PowderRUO
- Pen503B
Often used with
Compounds commonly discussed alongside DSIP in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
